Omnicom's healthcare revenue was up 2.7% in Q1
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
Shire considers splitting into two units; New Jersey finalizes physician-pharma gift limit; more biotech M&As expected in 2018
Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer's biosimilar to J&J's Remicade; Novartis to downsize generics business
FDA develops resources about biosimilars for HCPs; Biogen negotiates royalties for experimental Alzheimer's drug; GSK Q3 sales driven by HIV, respiratory drugs
By comparison, Omnicom's client roster includes less consumer goods companies compared to rivals WPP and Publicis Groupe.
Why is revenue growth at some of the agency groups lagging forecasts for global ad expenditure?
Find data on patent expirations, new drug approvals, top therapeutic classes, and top-selling drugs.
Sanofi to sell five OTC drugs to Ipsen; Teva reports 33% revenue growth in Q4; Regeneron issued subpoena about support of nonprofits
Novo Nordisk CEO describes 'volatile' pricing environment; Lilly to cut 200 research and development jobs; pharma opts out of Super Bowl this year
Biogen completes hemophilia spinoff; old drug being tested as a prostate cancer treatment; Merck reports Q4 decline in revenue
Valeant to sell stomach-drug business for $10 billion; Pfizer reports growth in third quarter; sales of hep.-C drugs drive revenue down for Gilead Sciences
Phunware's VP Product Evangelist will explore how hospitals can implement a wayfinding and messaging solution, and how they can expect to benefit from it.